A National Science Foundation-supported conference at NCSU over the next two days will explore the creation of a roadmap toward developing a national Internet of Things strategy. Here's a preview of what's going on.
A new research report from Juniper breaks down what its analysts view as the top disruptors in the financial technical services, or FinTech, space. Our WTW Insider subscribers get a look at the top three.
Latest for Insiders
Does HQ Raleigh's Big News Involve Charlotte's Packard Place? A Charleston Campus? Similar messaging on social media by startup hubs in Raleigh and Charlotte hint at big news for the state's startup ecosystem this week.
Watson will help Moogfest attendees compose their own songs, but there will be plenty of human performers, too, at the Durham event. New additions include synth-pop band Grimes and pop trio Mike Snow.
The former CEO and CFO of Salix Pharmaceuticals, which was sold to Valeant Pharmaceuticals for more than $11 billion a year ago, are being investigated by the SEC, according to the Reuters news service.
NC IDEA will launch its next round of awarding up to $50,000 in non-dilutive grants to startups on Feb. 15. Entrepreneurs can learn more about the program at a series of state-wide meetings. and webinars.
Amid the doom and gloom about a possible jobless future due to technology automation and robotics, a team of North Carolina School of Science and Mathematics - The Zebracorns - remain excited about the future.
Chimerix, which has a contract potentially worth more than $400 million in the development of a first vaccine targeting smallpox, reports progress in development of an antiviral. In recent tests, its brincidofovir successfully treated 100 percent of animals infected with rabbitpox.
Analysis: Cognizant is increasingly encroaching on IBM and Accenture's territory by building out its consulting scale and digital and cloud expertise, writes Technology Business research Analyst Jennifer Hamel. Our Insiders get the full story.
Talk about a sell-off. Early Monday, Triangle-based Biocryst disclosed news that a drug candidate targeting a rare genetic condition had failed. The news set off an immediate plunge in its share price, triggered a Wall Street downgrade - and a possible lawsuit.
Novan Therapeutics, a high-profile emerging pharmaceutical firm backed by big-name investors in the Triangle with a focus on developing new dermatology treatments, has a new chairman. But his name is a familiar one. Another well-known name leaves the board in the shuffle.
Is there a "Moore's Law" for technology-related job losses? Just as decades ago what came to be known as Moore's law forecast ever-increases in computer chip processing power, a new "law" has emerged: The faster technology develops, the more traditional jobs are lost. In a Q&A, NCSU Economist Mike Walden talks about the "jobless future" and how workers can avoid becoming obsolete.
Is a jobless future coming for North Carolina? As robotics, artificial intelligence and technology continue to evolve at a rapid rate, North Carolina faces a staggering 50 percent loss of jobs in the coming decades, according to an NCSU study. How can the state prevent such a debacle is the topic of a major forum in Raleigh.
Healthcare workers are hardly immune from the threat of a jobless future as being explored in this week's Emerging Issues Forum "Future Work" conference. But as one of speakers explains opportunities will remain available for humans in healthcare.
More than 50 emerging life science startups will have the chance to make their case for investment to possible backers at the CED's Life Science Conference next month. The CED announced its selections early Monday.
The 10th annual Southeast Venture Conference, which is the largest such event put on in the region, is set for March 16-17 in Tysons Corner, Va. Highlighting the program is a host of speakers ranging from startups and entrepreneurs to venture capitalists. Among the headliners: The founder of 500 Startups.